NHC.AU

3.61

-2.17%ā†“

NHC.AU

3.61

-2.17%ā†“

NHC.AU

3.61

-2.17%ā†“

NHC.AU

3.61

-2.17%ā†“

NHC.AU

3.61

-2.17%ā†“

Search

Sonic Healthcare Ltd

Gesloten

SectorGezondheidszorg

25.94 -0.04

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

25.26

Max

25.96

Belangrijke statistieken

By Trading Economics

Inkomsten

-72M

237M

Verkoop

6.8M

4.7B

K/W

Sectorgemiddelde

22.667

63.778

EPS

0.67

Dividendrendement

4.15

Winstmarge

5.07

Werknemers

42,000

EBITDA

-71M

839M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+15.1% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

4.15%

2.39%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.3B

12B

Vorige openingsprijs

25.98

Vorige sluitingsprijs

25.94

Nieuwssentiment

By Acuity

17%

83%

30 / 386 Rangschikking in Healthcare

Sonic Healthcare Ltd Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

21 aug 2024, 23:19 UTC

Winsten

Sonic Healthcare Raises Dividend Despite 25% Annual Profit Fall

22 aug 2024, 01:37 UTC

Marktinformatie

Sonic's Unchanged Profit Guidance Likely a Relief -- Market Talk

21 aug 2024, 23:00 UTC

Winsten

Sonic Healthcare Ebitda Excludes Gain on Sale of West Division in U.S.

21 aug 2024, 23:00 UTC

Winsten

Sonic Healthcare FY 2024 Ebitda A$1.60 Billion, Down 6.2%

21 aug 2024, 22:59 UTC

Winsten

Sonic Healthcare FY 2024 Base Business Revenue A$8.90 Billion, Up 16%

21 aug 2024, 22:59 UTC

Winsten

Sonic Healthcare FY 2024 Covid-19 Revenue A$62.4 Million, Down 87%

21 aug 2024, 22:58 UTC

Winsten

Sonic Healthcare Final Dividend A$0.63/Security

21 aug 2024, 22:58 UTC

Winsten

Sonic Healthcare FY Revenue A$8.97 Billion, Up 9.8%

21 aug 2024, 22:57 UTC

Winsten

Sonic Healthcare FY Net Profit A$511.1 Million, Down 25%

13 aug 2024, 00:29 UTC

Marktinformatie

Sonic's Cost Base in Focus at Annual Result -- Market Talk

22 mei 2024, 00:20 UTC

Marktinformatie

Sonic's FY 2025 Profit Guidance May Be Conservative -- Market Talk

21 mei 2024, 23:34 UTC

Marktinformatie

Sonic's Pathology Margins Likely Lower for Longer -- Market Talk

Peer Vergelijking

Prijswijziging

Sonic Healthcare Ltd Prognose

Koersdoel

By TipRanks

15.1% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 29.65Ā AUDĀ  15.1%

Hoogste 32.5Ā AUD

Laagste 26.5Ā AUD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Sonic Healthcare Ltd - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

11 ratings

2

Buy

8

Hold

1

Sell

Sentiment

By Acuity

30 / 386 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Sonic Healthcare Ltd

Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.